Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
C Kluft, … , G Dooijewaard, J J Sixma
C Kluft, … , G Dooijewaard, J J Sixma
Published November 1, 1987
Citation Information: J Clin Invest. 1987;80(5):1391-1400. https://doi.org/10.1172/JCI113217.
View: Text | PDF
Research Article

alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.

  • Text
  • PDF
Abstract

alpha 2-Antiplasmin (alpha 2-AP) is a major fibrinolysis inhibitor, whose complete, congenital absence has been found to be associated with a distinct hemorrhagic diathesis. We studied a 15-yr-old male with a hemorrhagic diathesis after trauma from early childhood on. This bleeding tendency was associated with a minimal alpha 2-AP level recorded functionally in the immediate plasmin inhibition test: less than or equal to 4% of normal. However, a normal plasma concentration of alpha 2-AP antigen (83%) was found. His sister (5 yr old) showed similar results (2 and 92%). In their family, eight heterozygotes could be identified by half-normal activity results and normal antigen concentrations. The inheritance pattern is autosomal recessive. On analysis, the alpha 2-AP of the propositus was homogeneous in all respects tested, suggesting a homozygous defect. We designated the abnormal alpha 2-AP as alpha 2-AP Enschede. alpha 2-AP Enschede showed the following characteristics: (a) complete immunological identity with normal alpha 2-AP; (b) normal molecular weight (sodium dodecyl sulfate-polyacrylamide gel electrophoresis); (c) normal alpha-electrophoretic mobility; (d) presence in plasma of both molecular forms excluding an excessive conversion to the less reactive non-plasminogen-binding form; (e) quantitatively normal binding to lys-plasminogen and to immobilized plasminogen kringle 1-3; and (f) normal Factor XIII-mediated binding to fibrin. Functional abnormalities were found in: (i) no inhibition of amidolytic activities of plasmin and trypsin, even on prolonged incubation; (ii) no formation of plasmin-antiplasmin complexes in plasma with plasmin added in excess; and (iii) no inhibition of fibrinolysis by fibrin-bound alpha 2-AP. In the heterozygotes, the presence of abnormal alpha 2-AP did not interfere with several functions of the residual normal alpha 2-AP. One-dimensional peptide mapping showed an abnormal pattern of papain digestion. We conclude that in this family, abnormal antiplasmin molecules, defective in plasmin inhibition but with normal plasminogen-binding properties, have been inherited. The residual plasminogen-binding properties do not protect against a hemorrhagic diathesis.

Authors

C Kluft, H K Nieuwenhuis, D C Rijken, E Groeneveld, G Wijngaards, W van Berkel, G Dooijewaard, J J Sixma

×

Total citations by year

Year: 2018 2016 2015 2008 2007 2005 2003 2002 2001 2000 1999 1997 1996 1995 1994 1992 1990 1989 1988 1987 Total
Citations: 1 1 1 2 1 2 1 2 4 1 3 1 2 2 1 3 2 5 2 1 38
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (38)

Title and authors Publication Year
Hemorrhagic disorders of fibrinolysis: a clinical review
JL Saes, SE Schols, WL van Heerde, MR Nijziel
Journal of Thrombosis and Haemostasis 2018
Role of heparin and non heparin binding serpins in coagulation and angiogenesis: A complex interplay
T Bhakuni, MF Ali, I Ahmad, S Bano, S Ansari, MA Jairajpuri
Archives of Biochemistry and Biophysics 2016
Assessment of Bleeding Risk in Patients with Cirrhosis
A Zanetto, M Senzolo, A Ferrarese, P Simioni, P Burra, KI Rodríguez-Castro
Current Hepatology Reports 2015
Reply
J Bommer, T Heinrich, H Heidt, V Hafner, E Jenetzky, I Walter-Sack, G Mikus
Nephrology Dialysis Transplantation 2008
α2-Antiplasmin and its deficiency: fibrinolysis out of balance
SL Carpenter, P Mathew
Haemophilia 2008
Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses
B Bouma, C Maas, BP Hazenberg, HM Lokhorst, MF Gebbink
Journal of Thrombosis and Haemostasis 2007
Antiplasmin
PB Coughlin
FEBS Journal 2005
The past, present and future of plasmin inhibitor
N Aoki
Thrombosis Research 2005
Lexikon der Syndrome und Fehlbildungen
R Witkowski, O Prokop, E Ullrich, G Thiel
2003
Affinity panning of peptide libraries using anti-streptokinase monoclonal antibodies: selection of an inhibitor of plasmin(ogen) active site
B Parhami-Seren, J Krudysz, P Tsantili
Journal of Immunological Methods 2002
Haemostatic abnormalities in patients with liver disease
T Lisman, FW Leebeek, PG de Groot
Journal of Hepatology 2002
Japanese Journal of Thrombosis and Hemostasis
M OKUDAIRA, H ASAKURA, Y SANO, Y SUGA, M YAMAZAKI, K AOSHIMA, E MORISHITA, M SAITO, Y ONTACHI, T MIZUTANI, M KATO, T ITO, K MIYAMOTO, S NAKAO
Japanese Journal of Thrombosis and Hemostasis 2001
Congenital alpha2-plasmin inhibitor deficiencies: a review
R Favier, N Aoki, P Moerloose
British Journal of Haematology 2001
Inactivation of the serpin α2-antiplasmin by stromelysin-1
HR Lijnen, BV Hoef, D Collen
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 2001
Fibrinolytics and Antifibrinolytics
F Bachmann
2001
A Simple Screening Assay for Certain Fibrinolysis Parameters (FIPA)
TW Stief, F Hinz, J Kurz, MO Doss, V Kretschmer
Thrombosis Research 2000
The Influence of Developmental Haemostasis on the Laboratory Diagnosis and Management of Haemostatic Disorders During Infancy and Childhood
C Male, M Johnston, C Sparling, LA Brooker, M Andrew, P Massicotte
Clinics in Laboratory Medicine 1999
Hämostaseologie
G Müller-Berghaus, B Pötzsch
Hämostaseologie 1999
Laboratory Techniques in Thrombosis - a Manual
J Jespersen, RM Bertina, F Haverkate
1999
Severe Postadenoidectomy Bleeding Revealing Congenital alpha2 Antiplasmin Deficiency in a Child:
X Paqueron, R Favier, P Richard, J Maillet, I Murat
Anesthesia & Analgesia 1997
Criteria for a specific plasmin inhibition test (SPIT) in human plasma
P Meijer, C Kluft
Fibrinolysis 1996
Operative Treatment of Intramedullary Hematoma Associated with Congenital Deficiency of alpha sub 2 -Plasmin Inhibitor.: A Report of Three Cases*
Y Miyauchi, Y Mii, M Aoki, S Tamai, Y Takahashi, A Yoshioka
The Journal of Bone and Joint Surgery. American volume. 1996
Structural basis for serpin inhibitor activity
HT Wright, JN Scarsdale
Proteins: Structure, Function, and Genetics 1995
4 Pathophysiology of fibrinolysis
I Juhan-Vague, MC Alessi, PJ Declerck
Baillière's Clinical Haematology 1995
Pathophysiology of fibrinolysis
PJ Declerck, I Juhan-Vague, J Felez, B Wiman
Journal of Internal Medicine 1994
Thrombin, a Link between Coagulation Activation and Fibrinolysis
RM Bertina, NH Tilburg, NJ Fouw, F Haverkate
Annals of the New York Academy of Sciences 1992
Assignment of the human α2-plasmin inhibitor gene (PLI) to chromosome 17, region pter-p12, by PCR analysis of somatic cell hybrids
SK Welch, U Francke
Genomics 1992
ECAT Assay Procedures A Manual of Laboratory Techniques
J Jespersen, RM Bertina, F Haverkate
1992
Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator
JL Heckel, EP Sandgren, JL Degen, RD Palmiter, RL Brinster
Cell 1990
Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis
CY Liu, S Chien
1990
Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence
O Miura, S Hirosawa, A Kato, N Aoki
Journal of Clinical Investigation 1989
Hemostasis associated with abnormalities of fibrinolysis
N Aoki
Blood Reviews 1989
Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin
C Kluft, AF Jie, P Los, E Wit, L Havekes
Biochemical and Biophysical Research Communications 1989
Hereditary α2-plasmin inhibitor deficiency caused by a transport-deficient mutation (α2-PI-Okinawa)
O Miura, Y Sugahara, N Aoki
The Journal of biological chemistry 1989
Clinical disorders of fibrinolysis: A critical review
RB Francis
Blut Zeitschrift für die Gesamte Blutforschung 1989
Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin
DC Rijken, E Groeneveld, C Kluft, HK Nieuwenhuis
Biochemical Journal 1988
The influence of thrombin and platelets on fibrin clot lysis rates in vitro: a study using a clot lysis system consisting of purified human proteins
NJ Fouw, YF Jong, F Haverkate, RM Bertina
Fibrinolysis 1988
α 2 -Antiplasmin Enschede: Alanine Insertion and Abolition of Plasmin Inhibitory Activity
WE Holmes, HR Lijnen, L Nelles, C Kluft, HK Nieuwenhuis, DC Rijken, D Collen
Science 1987

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts